Page 102 - NobleCon21

Health Care
Date November 20, 2025 Health Care
52wk High $2.75
52wk Low $0.67 Intelligent Bio Solutions Inc INBS $0.68
135 West, 41st Street
New York, NY 10036

(USD - in millions) ibs.inc
Market Cap 6.5
Enterprise 6.6
Basic Shares Out. 9.45 COMPANY OVERVIEW
Float 8.68
Institutional Holdings 10.38% Detailed Analysis:Channelchek.com
Short Interest 0.83
Avg. 90-Day Volume 0.29 Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology
company delivering intelligent, rapid, non-invasive testing solutions. Its
core product, the Intelligent Fingerprinting Drug Testing Solution, is the
first of its kind to detect drug use through fingerprint sweat. It screens
EPS Data for common drugs of abuse, including opiates, cocaine,
methamphetamine, and cannabis, offering an innovative alternative to
2022 2023 2024 traditional drug testing methods.
CQ1 (21.60) (68.64) (1.43)
CQ2 (33.60) (22.92) (0.51)

CQ3 (19.20) (12.48) N/A
CQ4 (5.52) (2.07) N/A
CY (79.92) (106.11) N/A Source: Channelchek/QuoteMedia

Long-Term EPS Estimate N/A
Price/Book (mrq) 0.40
ROE (ttm) -232.61
Debt-to-Total Cap. (mrq) 36.29
Fiscal Year End 30-Jun
135 West, 41s New York NY 10036

Key Executives
CEO: Simeonidis, Harry
CFO: Sakiris, Spiro
COO: Sequeira, Callistus
IR: N/A
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Robert LeBoyer MEMBERS: FINRA, SIPC, MSRB
rleboyer@noblelsp.com Following the conference, complete video library of presentations will be
available at: channelchek.com | nobleconference.com
(212) 896-4625

Refer to the back of the book for disclosures